Important Safety Information
Restylane®, Perlane®, and Restylane Fine Lines®:
Restylane® is intended for facial tissue augmentation. It is recommended for the correction of wrinkles and lip enhancement.
Perlane® is intended for facial tissue augmentation. It is recommended for shaping the contours of the face, correcting folds and lip enhancement.
Restylane Fine Lines® is intended for facial tissue augmentation. It is recommended for the correction of thin, superficial lines, for example periorbital lines, perioral lines, forehead lines and smile lines.
The most commonly observed side effects are swelling, redness, pain, itching, discolouration, and tenderness at the implant site. This will typically resolve within a week.
Additionally, temporary palpable lumpiness has been noted after use in some patients.
Avoid exposure of the treated area to intense heat, such as solarium and sunbathing, or extreme cold until any initial swelling and redness have resolved.
For each treatment session, the maximum dosage per treatment site is 0.8 mL for Restylane Fine Lines® and 2 mL for Restylane® and Perlane®.
The products have not been tested in pregnant or lactating women or in children.
Like any intradermal injection, the products are associated with an inherent risk of infection.
These products are only intended to be administered by a licensed health care professional in accordance with local legislation. Complete product and safety information is available below. Talk to your doctor to see if the Restylane® family of products is an appropriate treatment option for you, as it is not for everyone.
Restylane® pdf 
Perlane® pdf
Restylane Fine Lines® pdf